Komori
M

Matsuya R&D Co.,Ltd

7317Automobiles and transportation equipmentMicro cap
1,103JPY+0.3%
★ Watch (sign-up required)
Price history
¥1,103Latest+151.8%
Drag across the chart to measure the move between two points.Delayed 15 minutes · monthly closing basis
Business overview

The Group’s core business is the development, manufacture and sale of automated sewing machines, and it operates across 3 segments: Medical and Healthcare, Safety Systems and Other. The Group has production lines that use automated sewing machines common to each field, and develops, manufactures and sells medical and nursing-care products, including blood pressure monitor cuffs, automotive components such as car seats and airbags, and a wide range of sewing equipment for furniture and apparel applications. By leveraging its overseas bases in Europe, North America and Asia, the Group aims to ensure a stable supply, focusing on made-to-order production based on advance indications from major customers such as the OMRON Healthcare Group. Going forward, the Group plans to promote the development of next-generation technologies, including AI-equipped automated sewing machines, and contribute to improving customers’ productivity by meeting demand for automation in sewing processes. It will leverage synergies among its segments to expand its car-seat and airbag businesses, with sales of blood pressure monitor cuffs as the core.

Recurring subjects
No threads yetThis company's filings have not been read yet. We are adding them progressively.
Companies sharing a theme
Loading
Key numbersShowing 8 of 18
PER
15.26How many years of earnings it would take to buy the stock. The market average is generally considered to be around 15.
PBR
2.9How many times the company's net assets? Around 1x is generally considered a benchmark.
ROE
19.0%Earning power. A figure above 10% is generally considered good.
Dividend yield
0.0%The annual dividend as a percentage of the share price.
Market capitalization
¥24bnShare price × number of shares. The value of the entire company.
Equity ratio
65.2%The proportion of assets funded by money that does not have to be repaid.
Operating margin
21.8%The percentage of revenue remaining from the company’s core business.
Revenue growth (3 years)
10.9%The average annual growth in sales over the past three years.
What to watch next
Completion and start of operations at INNOVATION PLANT (headquarters site), scheduled for completion in June 2026
June-July 2026Impact MediumLikelihood Medium
Completion of the second Honai factory in Dong Nai Province, Vietnam, scheduled for September 2026, and the start of mass production
September 2026 through the first half of 2027Impact HighLikelihood Medium
Expansion from test shipments to initial delivery cases for Luna EMG, the EMG rehabilitation robot, providing greater clarity on recurring sales and orders
Second half of 2026 to 2027Impact MediumLikelihood Low
Continuation and growth of sales of the core Medical Healthcare product, blood pressure monitor cuffs, including confirmation of stable made-to-order production for the Omron Group
Next quarter through the full-year resultsImpact MediumLikelihood Medium
What to watch next
Loading
Who owns itTop holders total 79.2%
Listed holders 79.2%Everyone else 20.8%
Goto Tomohiro (後藤 倫啓)16.80%
Goto Masahiro (後藤 匡啓)16.80%
オムロンヘルスケア株式会社14.77%
ゴトウホールディング株式会社9.34%
Goto Hidetaka (後藤 秀隆)8.78%
MAEDA KOSEN CO.,LTD.3.73%
モルガン・スタンレーMUFG証券株式会社3.45%
上田八木短資株式会社2.33%
2 other listed holders3.16%
Who owns it
HolderOwnership (%)
Goto Tomohiro (後藤 倫啓)16.80
Goto Masahiro (後藤 匡啓)16.80
オムロンヘルスケア株式会社14.77
ゴトウホールディング株式会社9.34
Goto Hidetaka (後藤 秀隆)8.78
MAEDA KOSEN CO.,LTD.3.73
モルガン・スタンレーMUFG証券株式会社3.45
上田八木短資株式会社2.33
2 other listed holders3.16
This company's documents